https://doi.org/10.4081/monaldi.2020.1290
Chloroquine in COVID-19: the evidence
Published: March 31, 2020
Abstract Views: 14779
PDF: 8103
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
To the Editor
The Coronavirus disease 2019 (COVID-19) has been declared as a pandemic by World Health Organisation (WHO). The global mortality has increased, especially in countries like Italy and Iran. With the increasing morbidity and mortality, search for a cure has been the global demand.
How to Cite
Gupta, Nitesh, Sumita Agrawal, and Pranav Ish. 2020. “Chloroquine in COVID-19: The Evidence”. Monaldi Archives for Chest Disease 90 (1). https://doi.org/10.4081/monaldi.2020.1290.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- P.E. Van Schil, J.M. Hendriks, M.G. De Maeseneer, P.R. Lauwers, Current management of spontaneous pneumothorax , Monaldi Archives for Chest Disease: Vol. 63 No. 4 (2005): Pulmonary series
- Danilo di Diodoro, News and advertising on foods, diet and obesity , Monaldi Archives for Chest Disease: Vol. 64 No. 1 (2005): Cardiac series
- Paolo Biagi, Luigi Abate, Heart failure, oxidative stress and allopurinol , Monaldi Archives for Chest Disease: Vol. 64 No. 1 (2005): Cardiac series
- Marco Ambrosetti, Mario Salerno, Walter Ageno, Roberto Tramarin, Roberto FE Pedretti, Is physical training contraindicated in patients with deep vein thrombosis during cardiac rehabilitation? , Monaldi Archives for Chest Disease: Vol. 64 No. 1 (2005): Cardiac series
- Massimo F. Piepoli, Exercise Rehabilitation in Heart Disease: the real “polypill†for primary and secondary prevention , Monaldi Archives for Chest Disease: Vol. 64 No. 2 (2005): Cardiac series
- C. Incorvaia, F. Frati, P. Puccinelli, G.G. Riario-Sforza, S. Dal Bo, Dose dependence of efficacy and safety of subcutaneous immunotherapy , Monaldi Archives for Chest Disease: Vol. 65 No. 1 (2006): Pulmonary series
- G. Ciprandi, G.L. Marseglia, M.A. Tosca, Allergen-specific immunotherapy: an update on immunological mechanisms of action , Monaldi Archives for Chest Disease: Vol. 65 No. 1 (2006): Pulmonary series
- B. Chakrabarti, P.D.O. Davies, Pleural tuberculosis , Monaldi Archives for Chest Disease: Vol. 65 No. 1 (2006): Pulmonary series
- R.A. Stolarek, M. Kasielski, J. Rysz, P. Bialasiewicz, D. Nowak, Differential effect of cigarette smoking on hydrogen peroxide and thiobarbituric acid reactive substances exhaled in patients with community acquired pneumonia , Monaldi Archives for Chest Disease: Vol. 65 No. 1 (2006): Pulmonary series
- L. Proietti, L. Spicuzza, A. Di Maria, R. Polosa, E. Sebastian Torres, V. Asero, G.U. Di Maria, Non-occupational malignant pleural mesothelioma due to asbestos and non-asbestos fibres , Monaldi Archives for Chest Disease: Vol. 65 No. 4 (2006): Pulmonary series
<< < 4 5 6 7 8 9 10 11 12 13 > >>
You may also start an advanced similarity search for this article.
